- Home
- CLOV vs PEB Comparison
CLOV vs PEB Comparison
Compare CLOV & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- PEB
- Stock Information
- Founded
- CLOV 2014
- PEB 2009
- Country
- CLOV United States
- PEB United States
- Employees
- CLOV N/A
- PEB N/A
- Industry
- CLOV Medical Specialities
- PEB Real Estate Investment Trusts
- Sector
- CLOV Health Care
- PEB Real Estate
- Exchange
- CLOV Nasdaq
- PEB Nasdaq
- Market Cap
- CLOV 1.4B
- PEB 1.2B
- IPO Year
- CLOV N/A
- PEB 2009
- Fundamental
- Price
- CLOV $2.72
- PEB $10.70
- Analyst Decision
- CLOV Strong Buy
- PEB Hold
- Analyst Count
- CLOV 3
- PEB 8
- Target Price
- CLOV $4.37
- PEB $12.29
- AVG Volume (30 Days)
- CLOV 9.3M
- PEB 3.2M
- Earning Date
- CLOV 11-04-2025
- PEB 11-05-2025
- Dividend Yield
- CLOV N/A
- PEB 0.38%
- EPS Growth
- CLOV N/A
- PEB N/A
- EPS
- CLOV N/A
- PEB N/A
- Revenue
- CLOV $1,607,900,000.00
- PEB $1,469,933,000.00
- Revenue This Year
- CLOV $39.93
- PEB $2.18
- Revenue Next Year
- CLOV $28.94
- PEB $2.96
- P/E Ratio
- CLOV N/A
- PEB N/A
- Revenue Growth
- CLOV 22.12
- PEB 2.00
- 52 Week Low
- CLOV $2.12
- PEB $7.42
- 52 Week High
- CLOV $4.87
- PEB $15.12
- Technical
- Relative Strength Index (RSI)
- CLOV 44.10
- PEB 39.75
- Support Level
- CLOV $2.51
- PEB $11.33
- Resistance Level
- CLOV $3.26
- PEB $11.71
- Average True Range (ATR)
- CLOV 0.17
- PEB 0.32
- MACD
- CLOV -0.07
- PEB -0.15
- Stochastic Oscillator
- CLOV 26.19
- PEB 3.21
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.